Cargando…
Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making
BACKGROUND: Patient decision aids (PDAs) can support the treatment decision making process and empower patients to take a proactive role in their treatment pathway while using a shared decision-making (SDM) approach making participatory medicine possible. The aim of this study was to develop a PDA f...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624887/ https://www.ncbi.nlm.nih.gov/pubmed/31296199 http://dx.doi.org/10.1186/s12911-019-0862-4 |
_version_ | 1783434303054544896 |
---|---|
author | Ankolekar, Anshu Vanneste, Ben G. L. Bloemen-van Gurp, Esther van Roermund, Joep G. van Limbergen, Evert J. van de Beek, Kees Marcelissen, Tom Zambon, Victor Oelke, Matthias Dekker, Andre Roumen, Cheryl Lambin, Philippe Berlanga, Adriana Fijten, Rianne |
author_facet | Ankolekar, Anshu Vanneste, Ben G. L. Bloemen-van Gurp, Esther van Roermund, Joep G. van Limbergen, Evert J. van de Beek, Kees Marcelissen, Tom Zambon, Victor Oelke, Matthias Dekker, Andre Roumen, Cheryl Lambin, Philippe Berlanga, Adriana Fijten, Rianne |
author_sort | Ankolekar, Anshu |
collection | PubMed |
description | BACKGROUND: Patient decision aids (PDAs) can support the treatment decision making process and empower patients to take a proactive role in their treatment pathway while using a shared decision-making (SDM) approach making participatory medicine possible. The aim of this study was to develop a PDA for prostate cancer that is accurate and user-friendly. METHODS: We followed a user-centered design process consisting of five rounds of semi-structured interviews and usability surveys with topics such as informational/decisional needs of users and requirements for PDAs. Our user-base consisted of 8 urologists, 4 radiation oncologists, 2 oncology nurses, 8 general practitioners, 19 former prostate cancer patients, 4 usability experts and 11 healthy volunteers. RESULTS: Informational needs for patients centered on three key factors: treatment experience, post-treatment quality of life, and the impact of side effects. Patients and clinicians valued a PDA that presents balanced information on these factors through simple understandable language and visual aids. Usability questionnaires revealed that patients were more satisfied overall with the PDA than clinicians; however, both groups had concerns that the PDA might lengthen consultation times (42 and 41%, respectively). The PDA is accessible on http://beslissamen.nl/. CONCLUSIONS: User-centered design provided valuable insights into PDA requirements but challenges in integrating diverse perspectives as clinicians focus on clinical outcomes while patients also consider quality of life. Nevertheless, it is crucial to involve a broad base of clinical users in order to better understand the decision-making process and to develop a PDA that is accurate, usable, and acceptable. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12911-019-0862-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6624887 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66248872019-07-23 Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making Ankolekar, Anshu Vanneste, Ben G. L. Bloemen-van Gurp, Esther van Roermund, Joep G. van Limbergen, Evert J. van de Beek, Kees Marcelissen, Tom Zambon, Victor Oelke, Matthias Dekker, Andre Roumen, Cheryl Lambin, Philippe Berlanga, Adriana Fijten, Rianne BMC Med Inform Decis Mak Technical Advance BACKGROUND: Patient decision aids (PDAs) can support the treatment decision making process and empower patients to take a proactive role in their treatment pathway while using a shared decision-making (SDM) approach making participatory medicine possible. The aim of this study was to develop a PDA for prostate cancer that is accurate and user-friendly. METHODS: We followed a user-centered design process consisting of five rounds of semi-structured interviews and usability surveys with topics such as informational/decisional needs of users and requirements for PDAs. Our user-base consisted of 8 urologists, 4 radiation oncologists, 2 oncology nurses, 8 general practitioners, 19 former prostate cancer patients, 4 usability experts and 11 healthy volunteers. RESULTS: Informational needs for patients centered on three key factors: treatment experience, post-treatment quality of life, and the impact of side effects. Patients and clinicians valued a PDA that presents balanced information on these factors through simple understandable language and visual aids. Usability questionnaires revealed that patients were more satisfied overall with the PDA than clinicians; however, both groups had concerns that the PDA might lengthen consultation times (42 and 41%, respectively). The PDA is accessible on http://beslissamen.nl/. CONCLUSIONS: User-centered design provided valuable insights into PDA requirements but challenges in integrating diverse perspectives as clinicians focus on clinical outcomes while patients also consider quality of life. Nevertheless, it is crucial to involve a broad base of clinical users in order to better understand the decision-making process and to develop a PDA that is accurate, usable, and acceptable. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12911-019-0862-4) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-11 /pmc/articles/PMC6624887/ /pubmed/31296199 http://dx.doi.org/10.1186/s12911-019-0862-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Technical Advance Ankolekar, Anshu Vanneste, Ben G. L. Bloemen-van Gurp, Esther van Roermund, Joep G. van Limbergen, Evert J. van de Beek, Kees Marcelissen, Tom Zambon, Victor Oelke, Matthias Dekker, Andre Roumen, Cheryl Lambin, Philippe Berlanga, Adriana Fijten, Rianne Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making |
title | Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making |
title_full | Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making |
title_fullStr | Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making |
title_full_unstemmed | Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making |
title_short | Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making |
title_sort | development and validation of a patient decision aid for prostate cancer therapy: from paternalistic towards participative shared decision making |
topic | Technical Advance |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624887/ https://www.ncbi.nlm.nih.gov/pubmed/31296199 http://dx.doi.org/10.1186/s12911-019-0862-4 |
work_keys_str_mv | AT ankolekaranshu developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking AT vannestebengl developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking AT bloemenvangurpesther developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking AT vanroermundjoepg developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking AT vanlimbergenevertj developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking AT vandebeekkees developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking AT marcelissentom developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking AT zambonvictor developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking AT oelkematthias developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking AT dekkerandre developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking AT roumencheryl developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking AT lambinphilippe developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking AT berlangaadriana developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking AT fijtenrianne developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking |